Vukobrat-Bijedić Zora, Radović Svjetlana, Husić-Selimović Azra, Gornjaković Srdan
Gastroenterohepatology Clinic, University of Sarajevo Clinics Center, Bolnicka 25, 71000 Sarajevo, Bosnia and Herzegovina.
Bosn J Basic Med Sci. 2007 Feb;7(1):7-10. doi: 10.17305/bjbms.2007.3080.
The aim of the study was to verify the presence of mutated tumor suppresser gene p53 in intestinal mucosa with histologically confirmed premalignant lesions and gastric carcinoma, and assess its prognostic value. The paper presents prospective study that included 50 patients with gastric adeno-carcinoma of intestinal type that were treated at Gastroenterohepatology Clinic, and 50 patients with histologically confirmed chronic atrophic H. pylori positive gastritis. In the mucosa biopsy samples, we analyzed presence, frequency and severity of inflammatory-regenerative, metaplastic and dysplastic changes. We typed intestinal metaplasia immunohistochemically and confirmed the presence of p53 onco-protein in antigen positive gastric carcinoma cells, and evaluated its prognostic value. Our results suggest that H. pylori acts as an initiator of inflammatory processes in gastric mucosa, which are followed by emergence of precancerous lesions. p53 is expressed late in carcinogenesis (14%) and as such, may be considered as an indicator of transformation of premalignant into malignant lesion.
本研究的目的是验证在组织学确诊的癌前病变和胃癌的肠黏膜中是否存在突变的肿瘤抑制基因p53,并评估其预后价值。本文呈现了一项前瞻性研究,该研究纳入了50例在胃肠肝病诊所接受治疗的肠型胃腺癌患者,以及50例组织学确诊的慢性萎缩性幽门螺杆菌阳性胃炎患者。在黏膜活检样本中,我们分析了炎症再生、化生和发育异常变化的存在、频率和严重程度。我们通过免疫组织化学方法对肠化生进行分型,并在抗原阳性的胃癌细胞中证实了p53癌蛋白的存在,并评估了其预后价值。我们的结果表明,幽门螺杆菌是胃黏膜炎症过程的启动因素,随后会出现癌前病变。p53在致癌过程后期表达(14%),因此可被视为癌前病变向恶性病变转变的一个指标。